What is the conversion ratio for switching from intravenous (IV) Ativan (lorazepam) to IV Valium (diazepam)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

IV Lorazepam to IV Diazepam Conversion

The conversion ratio from IV lorazepam to IV diazepam is approximately 1:2 to 1:2.5, meaning 1 mg of IV lorazepam is equivalent to 2-2.5 mg of IV diazepam. 1

Conversion Ratio and Potency Differences

  • Lorazepam is approximately twice as potent as diazepam, with 2-2.5 mg of lorazepam providing equivalent sedative effects to 10 mg of diazepam 1
  • When converting from IV lorazepam to IV diazepam, multiply the lorazepam dose by 2 to 2.5 to determine the equivalent diazepam dose 1
  • For example, if a patient is receiving 4 mg IV lorazepam, the equivalent IV diazepam dose would be 8-10 mg 1

Critical Pharmacokinetic Differences to Consider

Duration of action differs significantly between these agents, which impacts clinical decision-making beyond simple dose conversion:

  • Diazepam has a much shorter duration of anticonvulsant activity (<2 hours) compared to lorazepam (up to 72 hours) 2
  • Diazepam is rapidly redistributed from the brain, with seizures often recurring within 15-20 minutes, necessitating immediate administration of a long-acting anticonvulsant like phenytoin or fosphenytoin 3, 4
  • Lorazepam provides prolonged anticonvulsant coverage and may be preferred for status epilepticus management due to its longer duration of action 3, 2

Clinical Efficacy Considerations

Lorazepam demonstrates superior efficacy in seizure management compared to diazepam:

  • In out-of-hospital status epilepticus, lorazepam terminated seizures in 59.1% of patients versus 42.6% for diazepam (odds ratio 1.9,95% CI 0.8-4.4) 5
  • Both agents show similar safety profiles regarding respiratory depression (10.6% for lorazepam vs 10.3% for diazepam) 5
  • Lorazepam as monotherapy is as effective as the diazepam-phenytoin combination in pediatric convulsive status epilepticus, with 100% success rates in both groups 6

Important Caveats When Converting

  • The conversion ratio applies to sedative equivalence, but clinical context matters: if converting for seizure management, lorazepam's longer duration of action means you may need more frequent diazepam dosing or concurrent long-acting anticonvulsant coverage 3, 2
  • Respiratory monitoring is essential with both agents, particularly when combined with other CNS depressants 3, 4
  • Venous thrombosis occurs less frequently with IV lorazepam compared to IV diazepam 1
  • The IM route is not recommended for diazepam due to tissue necrosis risk, whereas lorazepam can be given IM 3

Practical Dosing Algorithm

When converting from IV lorazepam to IV diazepam:

  1. Calculate the equivalent dose: Multiply lorazepam dose by 2-2.5 1
  2. Administer diazepam slowly over approximately 2 minutes to avoid pain at the IV site 3
  3. For seizure management, immediately follow with a long-acting anticonvulsant (phenytoin 18 mg/kg IV or fosphenytoin 20 mg PE/kg) due to diazepam's short duration 3, 4
  4. Monitor for respiratory depression and have ventilatory support immediately available 3, 4
  5. Consider whether conversion is clinically appropriate: lorazepam may be the superior choice for ongoing seizure management given its longer duration of action 2, 5

References

Research

Comparison of the actions of diazepam and lorazepam.

British journal of anaesthesia, 1979

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Seizure Management with Lorazepam

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Lorazepam versus diazepam-phenytoin combination in the treatment of convulsive status epilepticus in children: a randomized controlled trial.

European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.